Amy Law

1.5k total citations
75 papers, 1.1k citations indexed

About

Amy Law is a scholar working on Public Health, Environmental and Occupational Health, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Amy Law has authored 75 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 20 papers in Obstetrics and Gynecology and 18 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Amy Law's work include Reproductive Health and Contraception (19 papers), Respiratory viral infections research (16 papers) and Global Maternal and Child Health (14 papers). Amy Law is often cited by papers focused on Reproductive Health and Contraception (19 papers), Respiratory viral infections research (16 papers) and Global Maternal and Child Health (14 papers). Amy Law collaborates with scholars based in United States, United Kingdom and Germany. Amy Law's co-authors include Anna Filonenko, James Trussell, Fareen Hassan, Nathaniel Henry, Robert Brown, Kevin A. Schulman, Shelby D. Reed, John S. Sundy, R. Lynen and Thomas L. Kennedy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Amy Law

68 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Law United States	18	365	282	226	137	135	75	1.1k
J R Daling United States	17	250 0.7×	251 0.9×	219 1.0×	85 0.6×	111 0.8×	30	1.1k
M. Stead United Kingdom	15	242 0.7×	183 0.6×	123 0.5×	120 0.9×	83 0.6×	17	1.3k
Vivian W. Pinn United States	21	416 1.1×	54 0.2×	129 0.6×	134 1.0×	155 1.1×	64	1.7k
Rachel Peragallo Urrutia United States	17	540 1.5×	175 0.6×	214 0.9×	382 2.8×	241 1.8×	38	1.6k
Aparna Sundaram United States	17	505 1.4×	453 1.6×	129 0.6×	65 0.5×	131 1.0×	27	1.1k
É. Huyghe France	22	332 0.9×	187 0.7×	64 0.3×	582 4.2×	416 3.1×	146	2.0k
Tadeusz Dyba Finland	17	193 0.5×	186 0.7×	87 0.4×	113 0.8×	145 1.1×	41	1.3k
P. Babb United Kingdom	13	180 0.5×	136 0.5×	122 0.5×	64 0.5×	153 1.1×	22	1.4k
Martin Levitt Canada	18	312 0.9×	315 1.1×	60 0.3×	160 1.2×	161 1.2×	36	1.8k
Jimmy Hwang United States	16	172 0.5×	187 0.7×	46 0.2×	53 0.4×	95 0.7×	38	882

Countries citing papers authored by Amy Law

Since Specialization

Citations

This map shows the geographic impact of Amy Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Law more than expected).

Fields of papers citing papers by Amy Law

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Law. The network helps show where Amy Law may publish in the future.

Co-authorship network of co-authors of Amy Law

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Law. A scholar is included among the top collaborators of Amy Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Law. Amy Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Molina, Carlos A., et al.. (2025). Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico. Vaccines. 13(1). 77–77. 1 indexed citations

Atwood, Mark, et al.. (2025). Cost-effectiveness of bivalent respiratory syncytial virus Prefusion F (RSVpreF) maternal vaccine among infants in the United States. Vaccine. 58. 127191–127191. 2 indexed citations

Law, Amy, Jay Lin, Jennifer Judy, Sarah Pugh, & Alejandro Cané. (2025). Respiratory Syncytial Virus (RSV) Hospitalization Seasonal Patterns and Economic Burden in the US: Implications for Further Optimizing the Use of RSV Preventives. Vaccines. 13(4). 366–366.

Hauber, Brett, Kathleen Beusterien, Amy Law, et al.. (2024). A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United States. Human Vaccines & Immunotherapeutics. 20(1). 2358566–2358566. 8 indexed citations

Lyon, Aaron R., Clayton R. Cook, Madeline Larson, et al.. (2024). Protocol for a hybrid type 3 effectiveness-implementation trial of a pragmatic individual-level implementation strategy for supporting school-based prevention programming. Implementation Science. 19(1). 2–2. 5 indexed citations

Lyon, Aaron R., Freda F. Liu, Elizabeth H. Connors, et al.. (2022). How low can you go? Examining the effects of brief online training and post-training consultation dose on implementation mechanisms and outcomes for measurement-based care. SHILAP Revista de lepidopterología. 3(1). 79–79. 17 indexed citations

Filonenko, Anna, et al.. (2019). PIH36 ECONOMIC BURDEN OF UNINTENDED PREGNANCY IN THE UNITED STATES. Value in Health. 22. S188–S189. 1 indexed citations

Law, Amy, et al.. (2018). Twelve-month discontinuation rates of levonorgestrel intrauterine system 13.5 mg and subdermal etonogestrel implant in women aged 18–44: A retrospective claims database analysis. Contraception. 98(2). 120–124. 14 indexed citations

Law, Amy, et al.. (2017). Long-term outcomes after elective sterilization procedures — a comparative retrospective cohort study of Medicaid patients. Contraception. 97(5). 428–433. 2 indexed citations

10.

Law, Amy, Mark A. McCoy, R. Lynen, et al.. (2015). Costs of Newborn Care Following Complications During Pregnancy and Delivery. Maternal and Child Health Journal. 19(9). 2081–2088. 5 indexed citations

11.

Law, Amy, Mark A. McCoy, R. Lynen, et al.. (2015). The prevalence of complications and healthcare costs during pregnancy. Journal of Medical Economics. 18(7). 533–541. 36 indexed citations

12.

Trussell, James, Fareen Hassan, Julia Lowin, Amy Law, & Anna Filonenko. (2014). Achieving cost-neutrality with long-acting reversible contraceptive methods. Contraception. 91(1). 49–56. 54 indexed citations

13.

Ganz, Michael L., Dhvani Shah, Risha Gidwani, et al.. (2013). The Cost-Effectiveness of the Levonorgestrel-Releasing Intrauterine System for the Treatment of Idiopathic Heavy Menstrual Bleeding in the United States. Value in Health. 16(2). 325–333. 10 indexed citations

14.

Trussell, James, et al.. (2012). Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception. Contraception. 87(2). 154–161. 177 indexed citations

15.

Pocoski, Jennifer, et al.. (2011). PIH40 RETROSPECTIVE DATABASE ANALYSIS OF TREATMENT PATTERNS AND HEALTH CARE COSTS AMONG WOMEN WITH IDIOPATHIC HEAVY MENSTRUAL BLEEDING. Value in Health. 14(3). A112–A112. 1 indexed citations

16.

Farnsworth, Patricia N., et al.. (2009). Localization and quantification of intact, undamaged right-handed double-stranded B-DNA, and denatured single-stranded DNA in normal human epidermis and its effects on apoptosis and terminal differentiation (denucleation). Archives of Dermatological Research. 301(9). 659–672. 2 indexed citations

17.

Nurko, Samuel, et al.. (2007). Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: A retrospective cohort study. Clinical Therapeutics. 29(9). 2010–2021. 5 indexed citations

18.

Curtis, Lesley H., Amy Law, Kevin J. Anstrom, & Kevin A. Schulman. (2004). The Insurance Effect on Prescription Drug Expenditures Among the Elderly. Medical Care. 42(5). 439–446. 11 indexed citations

19.

Treadwell, Marsha, Amy Law, Jennifer Sung, et al.. (2004). Barriers to adherence of deferoxamine usage in sickle cell disease. Pediatric Blood & Cancer. 44(5). 500–507. 44 indexed citations

20.

Law, Amy, Shelby D. Reed, John S. Sundy, & Kevin A. Schulman. (2003). Direct costs of allergic rhinitis in the united states: Estimates from the 1996 medical expenditure panel survey. Journal of Allergy and Clinical Immunology. 111(2). 296–300. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact